 Christopher Lowry
Concepts (696)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Serotonin | 63 | 2025 | 319 | 10.620 |
Why?
| | Raphe Nuclei | 41 | 2019 | 110 | 9.480 |
Why?
| | Tryptophan Hydroxylase | 34 | 2022 | 55 | 6.260 |
Why?
| | Mycobacterium | 13 | 2024 | 106 | 5.480 |
Why?
| | Serotonergic Neurons | 17 | 2025 | 28 | 4.880 |
Why?
| | Anxiety | 46 | 2024 | 952 | 4.790 |
Why?
| | Stress, Psychological | 36 | 2025 | 1064 | 4.590 |
Why?
| | Mycobacteriaceae | 11 | 2023 | 21 | 4.250 |
Why?
| | Dorsal Raphe Nucleus | 15 | 2025 | 29 | 3.800 |
Why?
| | Proto-Oncogene Proteins c-fos | 24 | 2025 | 175 | 3.520 |
Why?
| | Neurons | 44 | 2022 | 1447 | 3.500 |
Why?
| | Corticotropin-Releasing Hormone | 18 | 2018 | 60 | 3.410 |
Why?
| | Amygdala | 21 | 2022 | 193 | 3.380 |
Why?
| | Rats | 84 | 2025 | 5246 | 3.350 |
Why?
| | Fear | 16 | 2023 | 347 | 3.250 |
Why?
| | Corticosterone | 25 | 2025 | 216 | 3.220 |
Why?
| | Behavior, Animal | 27 | 2025 | 502 | 3.220 |
Why?
| | Gastrointestinal Microbiome | 19 | 2024 | 641 | 3.190 |
Why?
| | Microbiota | 16 | 2024 | 724 | 2.890 |
Why?
| | Animals | 176 | 2025 | 34647 | 2.620 |
Why?
| | Stress Disorders, Post-Traumatic | 14 | 2023 | 821 | 2.270 |
Why?
| | Hyperthermia, Induced | 8 | 2024 | 108 | 2.250 |
Why?
| | Receptors, Corticotropin-Releasing Hormone | 9 | 2019 | 27 | 2.230 |
Why?
| | Depressive Disorder, Major | 11 | 2024 | 344 | 2.170 |
Why?
| | Inflammation | 28 | 2025 | 2666 | 2.150 |
Why?
| | Rats, Wistar | 34 | 2020 | 398 | 2.120 |
Why?
| | Probiotics | 4 | 2025 | 51 | 2.080 |
Why?
| | Anti-Inflammatory Agents | 9 | 2023 | 470 | 2.040 |
Why?
| | Rats, Sprague-Dawley | 35 | 2025 | 2272 | 2.020 |
Why?
| | Pituitary-Adrenal System | 12 | 2019 | 145 | 1.990 |
Why?
| | Antidepressive Agents | 10 | 2024 | 223 | 1.970 |
Why?
| | Hypothalamo-Hypophyseal System | 13 | 2019 | 178 | 1.960 |
Why?
| | Extinction, Psychological | 4 | 2023 | 88 | 1.910 |
Why?
| | Central Nervous System | 10 | 2022 | 254 | 1.770 |
Why?
| | Mental Health | 8 | 2024 | 683 | 1.710 |
Why?
| | Organic Cation Transport Proteins | 10 | 2025 | 30 | 1.690 |
Why?
| | Anxiety Disorders | 11 | 2021 | 351 | 1.690 |
Why?
| | Brain | 29 | 2024 | 2624 | 1.650 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 11 | 2022 | 74 | 1.610 |
Why?
| | Hippocampus | 9 | 2025 | 832 | 1.570 |
Why?
| | Panic Disorder | 7 | 2017 | 23 | 1.530 |
Why?
| | Male | 136 | 2025 | 63043 | 1.440 |
Why?
| | Fluoxetine | 7 | 2025 | 53 | 1.440 |
Why?
| | Hypothalamus | 7 | 2025 | 145 | 1.380 |
Why?
| | Motor Activity | 12 | 2021 | 669 | 1.350 |
Why?
| | Microglia | 6 | 2023 | 229 | 1.310 |
Why?
| | Glucocorticoids | 6 | 2023 | 573 | 1.270 |
Why?
| | Bacterial Vaccines | 4 | 2018 | 62 | 1.270 |
Why?
| | Lipopolysaccharides | 6 | 2023 | 859 | 1.210 |
Why?
| | Citalopram | 2 | 2018 | 30 | 1.160 |
Why?
| | Analysis of Variance | 23 | 2018 | 1273 | 1.160 |
Why?
| | Depression | 13 | 2024 | 1292 | 1.160 |
Why?
| | Social Isolation | 3 | 2013 | 60 | 1.140 |
Why?
| | Urocortins | 10 | 2019 | 22 | 1.130 |
Why?
| | Carbolines | 9 | 2015 | 27 | 1.120 |
Why?
| | Neural Pathways | 13 | 2025 | 297 | 1.120 |
Why?
| | Depressive Disorder | 3 | 2018 | 355 | 1.120 |
Why?
| | Environment, Controlled | 3 | 2016 | 20 | 1.100 |
Why?
| | Vaccines, Inactivated | 3 | 2018 | 68 | 1.100 |
Why?
| | Salamandridae | 11 | 2009 | 26 | 1.060 |
Why?
| | Body Temperature Regulation | 7 | 2019 | 96 | 1.060 |
Why?
| | Tryptophan | 9 | 2022 | 171 | 1.050 |
Why?
| | Mood Disorders | 3 | 2013 | 118 | 1.040 |
Why?
| | Immunomodulation | 3 | 2016 | 91 | 1.020 |
Why?
| | Dysbiosis | 2 | 2018 | 167 | 1.010 |
Why?
| | RNA, Ribosomal, 16S | 12 | 2024 | 522 | 1.000 |
Why?
| | Disease Models, Animal | 20 | 2023 | 3947 | 1.000 |
Why?
| | Immunohistochemistry | 20 | 2019 | 1668 | 0.980 |
Why?
| | Social Behavior | 8 | 2025 | 288 | 0.980 |
Why?
| | Cell Count | 14 | 2015 | 310 | 0.980 |
Why?
| | Anti-Anxiety Agents | 5 | 2023 | 42 | 0.970 |
Why?
| | Serotonin Receptor Agonists | 5 | 2017 | 28 | 0.970 |
Why?
| | Feces | 7 | 2024 | 442 | 0.940 |
Why?
| | RNA, Messenger | 9 | 2020 | 2679 | 0.930 |
Why?
| | Panic | 4 | 2017 | 10 | 0.920 |
Why?
| | Veterans | 8 | 2025 | 1397 | 0.900 |
Why?
| | Diet, Western | 1 | 2024 | 79 | 0.900 |
Why?
| | Stress, Physiological | 11 | 2014 | 413 | 0.890 |
Why?
| | Toxoplasmosis | 5 | 2025 | 36 | 0.880 |
Why?
| | Dorsomedial Hypothalamic Nucleus | 3 | 2015 | 5 | 0.870 |
Why?
| | Arousal | 6 | 2023 | 150 | 0.850 |
Why?
| | Receptor, Serotonin, 5-HT1A | 8 | 2019 | 38 | 0.830 |
Why?
| | Septal Nuclei | 3 | 2019 | 19 | 0.820 |
Why?
| | Weight Gain | 3 | 2024 | 504 | 0.820 |
Why?
| | Maternal Deprivation | 4 | 2019 | 16 | 0.820 |
Why?
| | Brain Injuries, Traumatic | 4 | 2020 | 337 | 0.810 |
Why?
| | Mental Disorders | 9 | 2024 | 1007 | 0.810 |
Why?
| | Caffeine | 5 | 2018 | 61 | 0.800 |
Why?
| | Inflammation Mediators | 3 | 2018 | 498 | 0.800 |
Why?
| | Reflex, Startle | 4 | 2019 | 68 | 0.790 |
Why?
| | Neurons, Afferent | 4 | 2012 | 86 | 0.780 |
Why?
| | Prefrontal Cortex | 3 | 2018 | 302 | 0.760 |
Why?
| | Cytomegalovirus Infections | 1 | 2023 | 186 | 0.760 |
Why?
| | Immunization | 9 | 2022 | 411 | 0.760 |
Why?
| | Toxoplasma | 4 | 2025 | 38 | 0.750 |
Why?
| | Carbon Dioxide | 4 | 2010 | 258 | 0.750 |
Why?
| | Hot Temperature | 3 | 2022 | 359 | 0.740 |
Why?
| | Hydroxyindoleacetic Acid | 11 | 2018 | 26 | 0.730 |
Why?
| | Veterans Health | 2 | 2024 | 175 | 0.730 |
Why?
| | Mice | 33 | 2024 | 16620 | 0.710 |
Why?
| | Colitis | 4 | 2019 | 240 | 0.700 |
Why?
| | Proteome | 1 | 2025 | 432 | 0.700 |
Why?
| | Body Temperature | 5 | 2024 | 212 | 0.680 |
Why?
| | Cerebrospinal Fluid Proteins | 1 | 2020 | 8 | 0.670 |
Why?
| | Exploratory Behavior | 5 | 2021 | 89 | 0.670 |
Why?
| | Humans | 93 | 2025 | 128495 | 0.670 |
Why?
| | Mice, Inbred BALB C | 12 | 2023 | 1227 | 0.670 |
Why?
| | Environment Design | 2 | 2016 | 26 | 0.650 |
Why?
| | Emotions | 5 | 2023 | 535 | 0.630 |
Why?
| | Synaptic Transmission | 4 | 2018 | 258 | 0.630 |
Why?
| | Interleukin-4 | 1 | 2020 | 212 | 0.620 |
Why?
| | Serotonin Agents | 4 | 2015 | 8 | 0.620 |
Why?
| | Locomotion | 6 | 2021 | 99 | 0.620 |
Why?
| | Dominance-Subordination | 2 | 2011 | 15 | 0.610 |
Why?
| | Interleukin-6 | 5 | 2024 | 715 | 0.590 |
Why?
| | Genes, fos | 2 | 2010 | 33 | 0.580 |
Why?
| | Blood Proteins | 1 | 2020 | 240 | 0.580 |
Why?
| | Catecholamines | 3 | 2005 | 97 | 0.570 |
Why?
| | Military Personnel | 3 | 2019 | 514 | 0.570 |
Why?
| | Housing, Animal | 2 | 2016 | 47 | 0.570 |
Why?
| | Behavior | 1 | 2018 | 92 | 0.570 |
Why?
| | Physical Conditioning, Animal | 2 | 2019 | 229 | 0.570 |
Why?
| | Signal Transduction | 5 | 2025 | 4825 | 0.570 |
Why?
| | Proteomics | 2 | 2025 | 1018 | 0.570 |
Why?
| | Swimming | 3 | 2021 | 47 | 0.560 |
Why?
| | Hypothermia | 1 | 2017 | 34 | 0.560 |
Why?
| | Gene Expression Regulation | 9 | 2018 | 2516 | 0.560 |
Why?
| | 8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 2017 | 9 | 0.560 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2013 | 819 | 0.550 |
Why?
| | Gastrointestinal Tract | 1 | 2019 | 183 | 0.550 |
Why?
| | Circadian Rhythm | 4 | 2021 | 412 | 0.540 |
Why?
| | Hypercapnia | 4 | 2012 | 49 | 0.540 |
Why?
| | Prebiotics | 3 | 2024 | 25 | 0.540 |
Why?
| | Psychological Trauma | 1 | 2017 | 54 | 0.530 |
Why?
| | Vaccination | 3 | 2020 | 1346 | 0.530 |
Why?
| | Pets | 3 | 2025 | 26 | 0.530 |
Why?
| | Lipid Metabolism | 1 | 2020 | 492 | 0.520 |
Why?
| | Parvalbumins | 2 | 2020 | 23 | 0.520 |
Why?
| | Suicide, Attempted | 4 | 2025 | 349 | 0.510 |
Why?
| | Immune System | 2 | 2014 | 176 | 0.510 |
Why?
| | Mice, Inbred C57BL | 13 | 2024 | 5281 | 0.490 |
Why?
| | Brain Concussion | 2 | 2020 | 544 | 0.490 |
Why?
| | Social Determinants of Health | 1 | 2018 | 221 | 0.480 |
Why?
| | Organic Anion Transporters, Sodium-Independent | 2 | 2019 | 4 | 0.480 |
Why?
| | Vasotocin | 4 | 2000 | 5 | 0.470 |
Why?
| | Gene Expression | 8 | 2020 | 1455 | 0.470 |
Why?
| | Post-Concussion Syndrome | 1 | 2017 | 164 | 0.450 |
Why?
| | Hormone Replacement Therapy | 1 | 2015 | 89 | 0.440 |
Why?
| | Immobility Response, Tonic | 1 | 2013 | 4 | 0.440 |
Why?
| | Conditioning, Classical | 5 | 2020 | 112 | 0.430 |
Why?
| | Cytokines | 7 | 2023 | 1994 | 0.430 |
Why?
| | Intestines | 2 | 2014 | 344 | 0.430 |
Why?
| | T-Lymphocytes, Regulatory | 3 | 2016 | 366 | 0.410 |
Why?
| | Pons | 2 | 2010 | 30 | 0.410 |
Why?
| | Mesencephalon | 2 | 2010 | 66 | 0.410 |
Why?
| | Public Health | 2 | 2022 | 482 | 0.410 |
Why?
| | Sex Characteristics | 2 | 2013 | 722 | 0.410 |
Why?
| | Life Style | 2 | 2014 | 459 | 0.400 |
Why?
| | Adaptation, Psychological | 3 | 2014 | 617 | 0.400 |
Why?
| | GABA Antagonists | 6 | 2013 | 31 | 0.400 |
Why?
| | Cold Temperature | 1 | 2013 | 154 | 0.390 |
Why?
| | Diet, High-Fat | 3 | 2024 | 238 | 0.390 |
Why?
| | Time Factors | 12 | 2015 | 6505 | 0.380 |
Why?
| | Prosencephalon | 6 | 2018 | 44 | 0.380 |
Why?
| | gamma-Aminobutyric Acid | 3 | 2017 | 157 | 0.380 |
Why?
| | GABAergic Neurons | 1 | 2012 | 28 | 0.380 |
Why?
| | Cushing Syndrome | 1 | 2011 | 10 | 0.380 |
Why?
| | Aging | 5 | 2024 | 1755 | 0.370 |
Why?
| | Kynurenine | 5 | 2018 | 105 | 0.370 |
Why?
| | DNA, Bacterial | 3 | 2024 | 324 | 0.370 |
Why?
| | Dose-Response Relationship, Drug | 12 | 2015 | 1951 | 0.370 |
Why?
| | Suicidal Ideation | 3 | 2025 | 463 | 0.360 |
Why?
| | Female | 40 | 2025 | 68266 | 0.360 |
Why?
| | Porphyromonas gingivalis | 2 | 2022 | 20 | 0.360 |
Why?
| | Rats, Long-Evans | 6 | 2021 | 134 | 0.360 |
Why?
| | Bronchi | 1 | 2012 | 241 | 0.350 |
Why?
| | Brain Mapping | 5 | 2007 | 572 | 0.350 |
Why?
| | Socioeconomic Factors | 2 | 2014 | 1212 | 0.350 |
Why?
| | Breast Neoplasms | 1 | 2022 | 2135 | 0.340 |
Why?
| | Bacteria | 6 | 2024 | 817 | 0.340 |
Why?
| | Suicide | 4 | 2020 | 577 | 0.340 |
Why?
| | Third Ventricle | 1 | 2010 | 17 | 0.340 |
Why?
| | Light | 3 | 2008 | 353 | 0.340 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2023 | 149 | 0.340 |
Why?
| | Animals, Newborn | 5 | 2018 | 808 | 0.330 |
Why?
| | Fenfluramine | 1 | 2009 | 13 | 0.320 |
Why?
| | Interneurons | 1 | 2010 | 119 | 0.320 |
Why?
| | Sequence Analysis, DNA | 2 | 2024 | 775 | 0.320 |
Why?
| | Cognition | 4 | 2022 | 1110 | 0.310 |
Why?
| | Amish | 2 | 2019 | 7 | 0.300 |
Why?
| | TRPV Cation Channels | 1 | 2008 | 32 | 0.300 |
Why?
| | Antibodies, Protozoan | 4 | 2025 | 32 | 0.300 |
Why?
| | Chromatography, High Pressure Liquid | 7 | 2018 | 488 | 0.300 |
Why?
| | Brain Chemistry | 4 | 2007 | 115 | 0.300 |
Why?
| | Medulla Oblongata | 4 | 2012 | 31 | 0.300 |
Why?
| | Sexual Behavior, Animal | 4 | 2006 | 54 | 0.290 |
Why?
| | RNA, Bacterial | 2 | 2020 | 183 | 0.280 |
Why?
| | Schizophrenia | 3 | 2016 | 428 | 0.280 |
Why?
| | Sleep Deprivation | 2 | 2020 | 171 | 0.280 |
Why?
| | Periaqueductal Gray | 3 | 2017 | 17 | 0.280 |
Why?
| | Encephalitis | 2 | 2020 | 133 | 0.280 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2008 | 136 | 0.280 |
Why?
| | Age Factors | 7 | 2021 | 3122 | 0.280 |
Why?
| | Relaxin | 2 | 2018 | 18 | 0.270 |
Why?
| | Proto-Oncogene Proteins c-fyn | 1 | 2007 | 12 | 0.270 |
Why?
| | Neuropeptides | 3 | 2018 | 71 | 0.270 |
Why?
| | Receptors, Interleukin-6 | 2 | 2024 | 37 | 0.270 |
Why?
| | Allosteric Site | 1 | 2007 | 19 | 0.270 |
Why?
| | Rats, Inbred F344 | 4 | 2019 | 255 | 0.270 |
Why?
| | Limbic System | 1 | 2007 | 46 | 0.270 |
Why?
| | Vaccines | 1 | 2012 | 396 | 0.270 |
Why?
| | Maze Learning | 6 | 2021 | 96 | 0.260 |
Why?
| | Restraint, Physical | 4 | 2015 | 67 | 0.260 |
Why?
| | Histamine | 2 | 2006 | 65 | 0.260 |
Why?
| | Up-Regulation | 4 | 2012 | 823 | 0.260 |
Why?
| | 5-Hydroxytryptophan | 5 | 2022 | 20 | 0.260 |
Why?
| | Indomethacin | 1 | 2006 | 77 | 0.250 |
Why?
| | Receptors, GABA-A | 1 | 2007 | 98 | 0.250 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 2006 | 80 | 0.250 |
Why?
| | Receptors, Serotonin, 5-HT3 | 1 | 2005 | 14 | 0.250 |
Why?
| | Benzodiazepines | 1 | 2007 | 130 | 0.250 |
Why?
| | Biguanides | 1 | 2005 | 12 | 0.250 |
Why?
| | Telemetry | 2 | 2017 | 40 | 0.250 |
Why?
| | In Situ Hybridization | 5 | 2012 | 291 | 0.250 |
Why?
| | Hypothalamic Area, Lateral | 1 | 2005 | 1 | 0.240 |
Why?
| | Prolactin | 2 | 2005 | 99 | 0.240 |
Why?
| | Environmental Microbiology | 2 | 2019 | 48 | 0.240 |
Why?
| | Microdialysis | 6 | 2025 | 51 | 0.230 |
Why?
| | Adult | 22 | 2025 | 35299 | 0.230 |
Why?
| | Vimentin | 1 | 2005 | 50 | 0.230 |
Why?
| | Adrenal Medulla | 1 | 2004 | 7 | 0.230 |
Why?
| | Life Change Events | 1 | 2005 | 147 | 0.230 |
Why?
| | Healthy Aging | 1 | 2024 | 34 | 0.230 |
Why?
| | Glucans | 1 | 2024 | 34 | 0.230 |
Why?
| | Fibroblast Growth Factor 8 | 2 | 2014 | 27 | 0.220 |
Why?
| | Intra-Abdominal Fat | 1 | 2024 | 88 | 0.220 |
Why?
| | Adjuvants, Pharmaceutic | 1 | 2023 | 10 | 0.220 |
Why?
| | Oligosaccharides | 1 | 2024 | 57 | 0.220 |
Why?
| | Progesterone | 2 | 2025 | 242 | 0.220 |
Why?
| | Helicobacter Infections | 2 | 2021 | 28 | 0.220 |
Why?
| | Neuroimmunomodulation | 2 | 2019 | 69 | 0.220 |
Why?
| | Dopamine | 3 | 2018 | 285 | 0.220 |
Why?
| | Paraventricular Hypothalamic Nucleus | 2 | 2018 | 26 | 0.220 |
Why?
| | Mice, Inbred Strains | 2 | 2023 | 402 | 0.220 |
Why?
| | Tuberculosis, Bovine | 1 | 2023 | 4 | 0.220 |
Why?
| | Estrogens | 2 | 2025 | 342 | 0.220 |
Why?
| | Bile Acids and Salts | 2 | 2024 | 194 | 0.220 |
Why?
| | Cerebral Cortex | 1 | 2007 | 423 | 0.210 |
Why?
| | Diazepam | 1 | 2023 | 27 | 0.210 |
Why?
| | Middle Aged | 15 | 2025 | 30921 | 0.210 |
Why?
| | Macrophages | 2 | 2023 | 1464 | 0.210 |
Why?
| | Leptin | 1 | 2024 | 218 | 0.210 |
Why?
| | Administration, Oral | 1 | 2025 | 767 | 0.200 |
Why?
| | Immunoglobulin G | 4 | 2024 | 844 | 0.200 |
Why?
| | Adjuvants, Immunologic | 1 | 2023 | 221 | 0.200 |
Why?
| | Receptors, Neuropeptide | 2 | 2012 | 12 | 0.200 |
Why?
| | Friends | 1 | 2023 | 52 | 0.200 |
Why?
| | Mucins | 1 | 2022 | 70 | 0.200 |
Why?
| | Random Allocation | 4 | 2009 | 344 | 0.200 |
Why?
| | Estradiol | 2 | 2025 | 489 | 0.190 |
Why?
| | Coinfection | 1 | 2023 | 131 | 0.190 |
Why?
| | Planets | 1 | 2021 | 1 | 0.190 |
Why?
| | Norepinephrine | 5 | 2005 | 210 | 0.190 |
Why?
| | Hydrazines | 3 | 2018 | 34 | 0.190 |
Why?
| | Serotonin Antagonists | 2 | 2015 | 31 | 0.190 |
Why?
| | Neopterin | 2 | 2022 | 12 | 0.190 |
Why?
| | Helicobacter pylori | 1 | 2021 | 37 | 0.180 |
Why?
| | Populus | 1 | 2021 | 9 | 0.180 |
Why?
| | Hygiene | 2 | 2014 | 29 | 0.180 |
Why?
| | Piperazines | 3 | 2010 | 333 | 0.180 |
Why?
| | Frailty | 1 | 2024 | 153 | 0.180 |
Why?
| | Adrenalectomy | 2 | 2015 | 66 | 0.180 |
Why?
| | Cholera Toxin | 3 | 2013 | 31 | 0.180 |
Why?
| | Epinephrine | 2 | 2005 | 140 | 0.180 |
Why?
| | Groundwater | 1 | 2021 | 37 | 0.180 |
Why?
| | Brain Stem | 3 | 2006 | 98 | 0.180 |
Why?
| | Carrier Proteins | 1 | 2005 | 732 | 0.180 |
Why?
| | United States | 7 | 2025 | 13840 | 0.180 |
Why?
| | Escape Reaction | 2 | 2017 | 62 | 0.170 |
Why?
| | Temporomandibular Joint | 1 | 2020 | 8 | 0.170 |
Why?
| | In Vitro Techniques | 3 | 2009 | 1047 | 0.170 |
Why?
| | Multiple Trauma | 1 | 2021 | 101 | 0.170 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2012 | 205 | 0.170 |
Why?
| | Gain of Function Mutation | 1 | 2020 | 34 | 0.170 |
Why?
| | Urban Population | 2 | 2025 | 441 | 0.170 |
Why?
| | Shock | 1 | 2021 | 92 | 0.170 |
Why?
| | Seasonal Affective Disorder | 1 | 2020 | 10 | 0.170 |
Why?
| | Mycobacterium tuberculosis | 1 | 2023 | 308 | 0.170 |
Why?
| | Neuropsychiatry | 1 | 2020 | 17 | 0.170 |
Why?
| | Receptors, Calcitriol | 1 | 2020 | 53 | 0.160 |
Why?
| | Adiposity | 1 | 2024 | 504 | 0.160 |
Why?
| | Communicable Diseases | 1 | 2022 | 145 | 0.160 |
Why?
| | Autoradiography | 2 | 2009 | 73 | 0.160 |
Why?
| | Periodontitis | 1 | 2020 | 49 | 0.160 |
Why?
| | Central Amygdaloid Nucleus | 1 | 2019 | 5 | 0.160 |
Why?
| | Mice, 129 Strain | 1 | 2019 | 79 | 0.160 |
Why?
| | Psycholinguistics | 1 | 2019 | 20 | 0.160 |
Why?
| | Sleep Disorders, Circadian Rhythm | 1 | 2019 | 37 | 0.160 |
Why?
| | Individuality | 2 | 2019 | 156 | 0.160 |
Why?
| | Phobic Disorders | 1 | 2019 | 31 | 0.160 |
Why?
| | United States Department of Veterans Affairs | 2 | 2024 | 635 | 0.150 |
Why?
| | Memory, Episodic | 1 | 2019 | 42 | 0.150 |
Why?
| | Animal Assisted Therapy | 1 | 2018 | 10 | 0.150 |
Why?
| | Health Promotion | 1 | 2024 | 716 | 0.150 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2023 | 348 | 0.150 |
Why?
| | Hypothalamus, Middle | 2 | 2010 | 2 | 0.150 |
Why?
| | Alarmins | 1 | 2018 | 24 | 0.150 |
Why?
| | Mice, Knockout | 4 | 2019 | 2765 | 0.150 |
Why?
| | Yohimbine | 2 | 2010 | 9 | 0.150 |
Why?
| | Housing | 1 | 2019 | 130 | 0.150 |
Why?
| | HMGB1 Protein | 1 | 2018 | 48 | 0.150 |
Why?
| | Biogenic Monoamines | 2 | 2009 | 15 | 0.150 |
Why?
| | Nervous System | 1 | 1998 | 66 | 0.140 |
Why?
| | Vasopressins | 1 | 1998 | 64 | 0.140 |
Why?
| | Vertebrates | 1 | 1998 | 58 | 0.140 |
Why?
| | Nesting Behavior | 1 | 2018 | 17 | 0.140 |
Why?
| | Phenylalanine | 1 | 2018 | 65 | 0.140 |
Why?
| | Adiponectin | 1 | 2020 | 234 | 0.140 |
Why?
| | Grooming | 2 | 2009 | 6 | 0.140 |
Why?
| | Injections, Intraventricular | 2 | 2009 | 55 | 0.140 |
Why?
| | MicroRNAs | 2 | 2014 | 674 | 0.140 |
Why?
| | Trauma and Stressor Related Disorders | 1 | 2017 | 2 | 0.140 |
Why?
| | Autism Spectrum Disorder | 2 | 2020 | 385 | 0.140 |
Why?
| | Amphibians | 1 | 1998 | 52 | 0.140 |
Why?
| | Desipramine | 2 | 2015 | 10 | 0.140 |
Why?
| | Food Chain | 1 | 2017 | 37 | 0.140 |
Why?
| | Genetic Fitness | 1 | 2018 | 54 | 0.140 |
Why?
| | Pilot Projects | 2 | 2024 | 1568 | 0.140 |
Why?
| | Songbirds | 1 | 2018 | 39 | 0.140 |
Why?
| | Tyrosine | 1 | 2018 | 218 | 0.140 |
Why?
| | Noise | 1 | 2018 | 67 | 0.140 |
Why?
| | Receptors, Glucocorticoid | 2 | 2017 | 148 | 0.140 |
Why?
| | Biomarkers | 3 | 2024 | 3893 | 0.140 |
Why?
| | Helicobacter | 1 | 2016 | 4 | 0.140 |
Why?
| | Impulsive Behavior | 1 | 2018 | 128 | 0.130 |
Why?
| | Gliadin | 1 | 2016 | 13 | 0.130 |
Why?
| | Tissue Distribution | 3 | 2006 | 296 | 0.130 |
Why?
| | Soil Microbiology | 1 | 2019 | 205 | 0.130 |
Why?
| | Altitude | 1 | 2021 | 452 | 0.130 |
Why?
| | Lipids | 1 | 2020 | 621 | 0.130 |
Why?
| | Hydrocortisone | 2 | 2018 | 304 | 0.130 |
Why?
| | Video Recording | 2 | 2009 | 161 | 0.130 |
Why?
| | Psychomotor Performance | 1 | 2019 | 312 | 0.130 |
Why?
| | Nerve Tissue Proteins | 2 | 2018 | 570 | 0.130 |
Why?
| | Young Adult | 7 | 2025 | 12349 | 0.130 |
Why?
| | Obesity | 3 | 2024 | 2864 | 0.130 |
Why?
| | Drug Administration Routes | 2 | 2007 | 38 | 0.130 |
Why?
| | Down-Regulation | 1 | 2018 | 632 | 0.130 |
Why?
| | Immunity, Cellular | 1 | 2018 | 263 | 0.130 |
Why?
| | Species Specificity | 3 | 2023 | 569 | 0.130 |
Why?
| | Biogenic Amines | 1 | 1996 | 4 | 0.130 |
Why?
| | Sick Building Syndrome | 1 | 2015 | 4 | 0.130 |
Why?
| | Epilepsy | 1 | 2020 | 323 | 0.130 |
Why?
| | Rectum | 1 | 2017 | 169 | 0.130 |
Why?
| | Adrenal Glands | 2 | 2016 | 70 | 0.130 |
Why?
| | Affect | 1 | 2018 | 284 | 0.120 |
Why?
| | Combined Modality Therapy | 1 | 2018 | 1201 | 0.120 |
Why?
| | Cohort Studies | 3 | 2024 | 5402 | 0.120 |
Why?
| | Membrane Potentials | 1 | 1996 | 264 | 0.120 |
Why?
| | Staining and Labeling | 2 | 2006 | 137 | 0.120 |
Why?
| | Radioimmunoassay | 2 | 2009 | 169 | 0.120 |
Why?
| | Leukocytes, Mononuclear | 1 | 2018 | 539 | 0.120 |
Why?
| | Cross-Sectional Studies | 2 | 2024 | 5045 | 0.120 |
Why?
| | Argonaute Proteins | 1 | 2014 | 28 | 0.120 |
Why?
| | Learning | 1 | 2019 | 399 | 0.120 |
Why?
| | Feedback, Physiological | 1 | 2015 | 76 | 0.120 |
Why?
| | Receptors, Steroid | 1 | 1995 | 49 | 0.120 |
Why?
| | Sleep | 4 | 2021 | 682 | 0.110 |
Why?
| | Quality of Life | 2 | 2024 | 2688 | 0.110 |
Why?
| | Receptors, Adrenergic, beta-1 | 1 | 2014 | 46 | 0.110 |
Why?
| | Metabolic Networks and Pathways | 1 | 2015 | 175 | 0.110 |
Why?
| | Diet | 4 | 2024 | 1204 | 0.110 |
Why?
| | Extracellular Space | 2 | 2019 | 119 | 0.110 |
Why?
| | Urbanization | 1 | 2014 | 26 | 0.110 |
Why?
| | Chronic Disease | 2 | 2019 | 1692 | 0.110 |
Why?
| | White Matter | 1 | 2016 | 134 | 0.110 |
Why?
| | Rural Population | 1 | 2018 | 517 | 0.110 |
Why?
| | Hypoxia | 1 | 2021 | 1035 | 0.110 |
Why?
| | Alzheimer Disease | 1 | 2020 | 517 | 0.110 |
Why?
| | Proteins | 1 | 2020 | 936 | 0.110 |
Why?
| | Oncogene Proteins v-fos | 1 | 2013 | 11 | 0.110 |
Why?
| | Biological Evolution | 2 | 2014 | 428 | 0.110 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2014 | 52 | 0.110 |
Why?
| | Bradycardia | 2 | 2012 | 53 | 0.110 |
Why?
| | Antidepressive Agents, Tricyclic | 1 | 2013 | 30 | 0.110 |
Why?
| | Emigration and Immigration | 1 | 2014 | 50 | 0.110 |
Why?
| | Comorbidity | 2 | 2017 | 1541 | 0.110 |
Why?
| | Cognitive Dysfunction | 1 | 2018 | 343 | 0.110 |
Why?
| | Receptors, Opioid | 2 | 1990 | 21 | 0.110 |
Why?
| | Respiration Disorders | 1 | 2014 | 72 | 0.110 |
Why?
| | Receptors, Angiotensin | 1 | 2013 | 12 | 0.110 |
Why?
| | Follow-Up Studies | 3 | 2018 | 4874 | 0.100 |
Why?
| | Deoxyadenine Nucleotides | 1 | 2013 | 13 | 0.100 |
Why?
| | Rodentia | 1 | 2013 | 48 | 0.100 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 3 | 2021 | 820 | 0.100 |
Why?
| | Skin | 3 | 2023 | 717 | 0.100 |
Why?
| | Adrenocorticotropic Hormone | 2 | 2011 | 133 | 0.100 |
Why?
| | Amphetamine | 1 | 2012 | 22 | 0.100 |
Why?
| | Body Weight | 1 | 2017 | 933 | 0.100 |
Why?
| | Avoidance Learning | 1 | 2013 | 68 | 0.100 |
Why?
| | Angiotensin II | 1 | 2013 | 93 | 0.100 |
Why?
| | Serotonin 5-HT1 Receptor Agonists | 1 | 2012 | 4 | 0.100 |
Why?
| | Sodium Lactate | 2 | 2013 | 5 | 0.100 |
Why?
| | Resilience, Psychological | 1 | 2014 | 122 | 0.100 |
Why?
| | Brain Injuries | 1 | 2017 | 465 | 0.100 |
Why?
| | Weaning | 1 | 2012 | 48 | 0.100 |
Why?
| | Aged | 5 | 2024 | 21974 | 0.090 |
Why?
| | Phenotype | 3 | 2021 | 3051 | 0.090 |
Why?
| | Homeostasis | 1 | 2015 | 606 | 0.090 |
Why?
| | Metagenomics | 2 | 2024 | 156 | 0.090 |
Why?
| | Memory | 3 | 2018 | 254 | 0.090 |
Why?
| | ATP-Binding Cassette Transporters | 2 | 2002 | 130 | 0.090 |
Why?
| | Electroshock | 3 | 2017 | 147 | 0.090 |
Why?
| | Cell Line, Transformed | 1 | 2011 | 141 | 0.090 |
Why?
| | Hypertension | 2 | 2012 | 1236 | 0.090 |
Why?
| | Neuronal Tract-Tracers | 1 | 2010 | 2 | 0.090 |
Why?
| | Radiography | 1 | 2013 | 795 | 0.090 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2012 | 172 | 0.090 |
Why?
| | Sanitation | 1 | 2010 | 52 | 0.090 |
Why?
| | Receptor, Serotonin, 5-HT2A | 1 | 2010 | 20 | 0.090 |
Why?
| | Gene-Environment Interaction | 1 | 2012 | 185 | 0.090 |
Why?
| | Receptors, Adrenergic | 2 | 2006 | 34 | 0.090 |
Why?
| | Cell Lineage | 1 | 2012 | 336 | 0.080 |
Why?
| | Injections, Intraperitoneal | 2 | 2009 | 109 | 0.080 |
Why?
| | Environmental Exposure | 1 | 2014 | 461 | 0.080 |
Why?
| | HIV Infections | 1 | 2024 | 2711 | 0.080 |
Why?
| | Catheters, Indwelling | 1 | 2010 | 79 | 0.080 |
Why?
| | Feeding Behavior | 2 | 2006 | 619 | 0.080 |
Why?
| | Social Dominance | 1 | 2009 | 17 | 0.080 |
Why?
| | Green Fluorescent Proteins | 1 | 2011 | 380 | 0.080 |
Why?
| | Aromatic Amino Acid Decarboxylase Inhibitors | 1 | 2009 | 1 | 0.080 |
Why?
| | Tyrosine 3-Monooxygenase | 2 | 2007 | 73 | 0.080 |
Why?
| | Thermosensing | 1 | 2008 | 11 | 0.080 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2012 | 433 | 0.080 |
Why?
| | Neuropsychological Tests | 2 | 2020 | 1005 | 0.080 |
Why?
| | Pyridines | 2 | 2013 | 474 | 0.080 |
Why?
| | Amino Acid Sequence | 2 | 2011 | 2044 | 0.080 |
Why?
| | Transfection | 1 | 2011 | 896 | 0.080 |
Why?
| | Pargyline | 1 | 2008 | 2 | 0.080 |
Why?
| | N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2008 | 10 | 0.080 |
Why?
| | Biological Transport | 2 | 2006 | 396 | 0.080 |
Why?
| | Seroepidemiologic Studies | 2 | 2019 | 156 | 0.080 |
Why?
| | Temperature | 1 | 2011 | 632 | 0.070 |
Why?
| | Mice, Transgenic | 4 | 2014 | 2069 | 0.070 |
Why?
| | Immune Tolerance | 1 | 2010 | 350 | 0.070 |
Why?
| | T-Lymphocyte Subsets | 1 | 2010 | 409 | 0.070 |
Why?
| | Central Nervous System Stimulants | 2 | 2012 | 153 | 0.070 |
Why?
| | Somatoform Disorders | 1 | 2007 | 31 | 0.070 |
Why?
| | Exercise | 2 | 2024 | 1918 | 0.070 |
Why?
| | Self Report | 2 | 2024 | 797 | 0.070 |
Why?
| | Acoustic Stimulation | 1 | 2009 | 328 | 0.070 |
Why?
| | Bronchopulmonary Sequestration | 1 | 2007 | 8 | 0.070 |
Why?
| | Statistics as Topic | 1 | 2008 | 304 | 0.070 |
Why?
| | Seasons | 2 | 2020 | 498 | 0.070 |
Why?
| | Synapses | 1 | 2010 | 384 | 0.070 |
Why?
| | Tryptamines | 1 | 2006 | 5 | 0.070 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2007 | 132 | 0.070 |
Why?
| | Darkness | 1 | 2006 | 25 | 0.070 |
Why?
| | Evidence-Based Medicine | 1 | 2010 | 712 | 0.070 |
Why?
| | Tegmentum Mesencephali | 1 | 2006 | 5 | 0.060 |
Why?
| | Genotype | 3 | 2020 | 1830 | 0.060 |
Why?
| | Heart Rate | 2 | 2025 | 798 | 0.060 |
Why?
| | Tissue Fixation | 1 | 2005 | 34 | 0.060 |
Why?
| | Chromatography, Liquid | 2 | 2021 | 381 | 0.060 |
Why?
| | Cell Membrane | 2 | 2022 | 725 | 0.060 |
Why?
| | Peptide Fragments | 2 | 2008 | 688 | 0.060 |
Why?
| | Blood-Brain Barrier | 1 | 2006 | 126 | 0.060 |
Why?
| | Drug Interactions | 1 | 2007 | 361 | 0.060 |
Why?
| | Median Eminence | 1 | 2005 | 5 | 0.060 |
Why?
| | Arcuate Nucleus of Hypothalamus | 1 | 2005 | 13 | 0.060 |
Why?
| | Stilbamidines | 1 | 2005 | 10 | 0.060 |
Why?
| | Injections | 1 | 2005 | 173 | 0.060 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2009 | 737 | 0.060 |
Why?
| | Adrenergic alpha-Antagonists | 1 | 2005 | 33 | 0.060 |
Why?
| | Heart Atria | 1 | 2005 | 128 | 0.060 |
Why?
| | Autoimmunity | 1 | 2010 | 860 | 0.060 |
Why?
| | Blood Pressure | 2 | 2013 | 1712 | 0.060 |
Why?
| | Nerve Fibers | 1 | 2005 | 87 | 0.060 |
Why?
| | Microinjections | 2 | 2015 | 83 | 0.060 |
Why?
| | Neurons, Efferent | 1 | 2004 | 8 | 0.060 |
Why?
| | Mind-Body Therapies | 1 | 2024 | 6 | 0.060 |
Why?
| | Genes, Immediate-Early | 1 | 2004 | 19 | 0.060 |
Why?
| | Perfusion | 1 | 2005 | 188 | 0.060 |
Why?
| | Lomustine | 1 | 2024 | 14 | 0.060 |
Why?
| | Ovariectomy | 1 | 2025 | 136 | 0.060 |
Why?
| | Sympathetic Nervous System | 1 | 2005 | 173 | 0.060 |
Why?
| | Colorado | 2 | 2024 | 4399 | 0.060 |
Why?
| | Risk Factors | 3 | 2025 | 9737 | 0.060 |
Why?
| | Mouth | 1 | 2024 | 80 | 0.060 |
Why?
| | Reproducibility of Results | 2 | 2024 | 3021 | 0.050 |
Why?
| | Metagenome | 1 | 2024 | 140 | 0.050 |
Why?
| | Action Potentials | 2 | 2011 | 469 | 0.050 |
Why?
| | Pregnancy | 4 | 2022 | 6373 | 0.050 |
Why?
| | Saliva | 1 | 2025 | 210 | 0.050 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2020 | 2064 | 0.050 |
Why?
| | Drosophila Proteins | 2 | 2002 | 187 | 0.050 |
Why?
| | Prednisone | 1 | 2024 | 230 | 0.050 |
Why?
| | Rats, Inbred Lew | 1 | 2003 | 92 | 0.050 |
Why?
| | Neurodegenerative Diseases | 1 | 2024 | 112 | 0.050 |
Why?
| | Immunoglobulin M | 1 | 2024 | 272 | 0.050 |
Why?
| | Psychiatric Status Rating Scales | 2 | 2016 | 521 | 0.050 |
Why?
| | Carbidopa | 1 | 2022 | 4 | 0.050 |
Why?
| | Orexin Receptors | 2 | 2012 | 4 | 0.050 |
Why?
| | Psychoneuroimmunology | 1 | 2022 | 8 | 0.050 |
Why?
| | Fever | 1 | 2024 | 297 | 0.050 |
Why?
| | Blood Glucose | 2 | 2011 | 2092 | 0.050 |
Why?
| | Blotting, Western | 1 | 2005 | 1170 | 0.050 |
Why?
| | Fathers | 1 | 2022 | 48 | 0.050 |
Why?
| | Models, Biological | 2 | 2007 | 1698 | 0.050 |
Why?
| | Polysomnography | 2 | 2019 | 161 | 0.050 |
Why?
| | Eye | 1 | 2002 | 105 | 0.050 |
Why?
| | Bacteroidetes | 1 | 2021 | 23 | 0.050 |
Why?
| | Counseling | 1 | 2024 | 384 | 0.050 |
Why?
| | Endophenotypes | 1 | 2021 | 18 | 0.050 |
Why?
| | Anhedonia | 1 | 2021 | 11 | 0.050 |
Why?
| | Nontuberculous Mycobacteria | 1 | 2023 | 199 | 0.050 |
Why?
| | Supervised Machine Learning | 1 | 2021 | 17 | 0.050 |
Why?
| | Granulocytes | 1 | 2021 | 79 | 0.050 |
Why?
| | Pregnancy Trimester, First | 1 | 2022 | 138 | 0.050 |
Why?
| | Social Justice | 1 | 2022 | 78 | 0.050 |
Why?
| | Microfilament Proteins | 1 | 2022 | 125 | 0.050 |
Why?
| | Biodegradation, Environmental | 1 | 2021 | 82 | 0.050 |
Why?
| | Linkage Disequilibrium | 1 | 2001 | 257 | 0.040 |
Why?
| | Dietary Sucrose | 1 | 2021 | 48 | 0.040 |
Why?
| | Rivers | 1 | 2021 | 66 | 0.040 |
Why?
| | Trees | 1 | 2021 | 69 | 0.040 |
Why?
| | Dreams | 1 | 2000 | 11 | 0.040 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 1 | 2021 | 236 | 0.040 |
Why?
| | Toll-Like Receptor 4 | 1 | 2023 | 263 | 0.040 |
Why?
| | Cations | 1 | 2021 | 79 | 0.040 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2024 | 487 | 0.040 |
Why?
| | Microelectrodes | 1 | 2000 | 42 | 0.040 |
Why?
| | Choice Behavior | 1 | 2022 | 165 | 0.040 |
Why?
| | Cattle | 1 | 2023 | 965 | 0.040 |
Why?
| | Calcium-Binding Proteins | 1 | 2022 | 209 | 0.040 |
Why?
| | Social Support | 1 | 2024 | 589 | 0.040 |
Why?
| | Policy | 1 | 2022 | 144 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2024 | 863 | 0.040 |
Why?
| | Benzomorphans | 2 | 1990 | 2 | 0.040 |
Why?
| | Program Evaluation | 1 | 2024 | 872 | 0.040 |
Why?
| | Positive-Pressure Respiration | 1 | 2000 | 75 | 0.040 |
Why?
| | Cathelicidins | 1 | 2020 | 37 | 0.040 |
Why?
| | DNA, Ribosomal | 1 | 2020 | 83 | 0.040 |
Why?
| | Sleep Apnea Syndromes | 1 | 2000 | 80 | 0.040 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2020 | 77 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2024 | 1856 | 0.040 |
Why?
| | ROC Curve | 1 | 2021 | 502 | 0.040 |
Why?
| | Normetanephrine | 1 | 2019 | 2 | 0.040 |
Why?
| | Chromosome Mapping | 1 | 2020 | 504 | 0.040 |
Why?
| | Bipolar Disorder | 1 | 2001 | 233 | 0.040 |
Why?
| | Dextran Sulfate | 1 | 2019 | 77 | 0.040 |
Why?
| | Administration, Intranasal | 1 | 2019 | 83 | 0.040 |
Why?
| | Lymphocytes | 1 | 2021 | 368 | 0.040 |
Why?
| | Social Environment | 2 | 2010 | 291 | 0.040 |
Why?
| | Photic Stimulation | 1 | 2020 | 239 | 0.040 |
Why?
| | Axons | 1 | 2000 | 188 | 0.040 |
Why?
| | Reaction Time | 1 | 2000 | 407 | 0.040 |
Why?
| | Asthma | 1 | 2012 | 2213 | 0.040 |
Why?
| | Electroencephalography | 1 | 2021 | 396 | 0.040 |
Why?
| | Patient Care Team | 1 | 2024 | 598 | 0.040 |
Why?
| | Patient-Centered Care | 1 | 2024 | 497 | 0.040 |
Why?
| | Interpersonal Relations | 2 | 2015 | 390 | 0.040 |
Why?
| | Tandem Mass Spectrometry | 1 | 2021 | 456 | 0.040 |
Why?
| | Genetic Testing | 1 | 2001 | 428 | 0.040 |
Why?
| | Optogenetics | 1 | 2020 | 112 | 0.040 |
Why?
| | Wakefulness | 1 | 2019 | 120 | 0.040 |
Why?
| | Metabolome | 1 | 2021 | 320 | 0.040 |
Why?
| | Task Performance and Analysis | 1 | 2019 | 173 | 0.040 |
Why?
| | Quantitative Trait Loci | 1 | 2020 | 355 | 0.040 |
Why?
| | Serologic Tests | 1 | 2018 | 50 | 0.040 |
Why?
| | Extracellular Fluid | 2 | 2010 | 31 | 0.040 |
Why?
| | Germany | 1 | 2018 | 98 | 0.040 |
Why?
| | Agoraphobia | 1 | 2017 | 7 | 0.040 |
Why?
| | Feathers | 1 | 2018 | 37 | 0.040 |
Why?
| | Nucleic Acid Probes | 1 | 1997 | 1 | 0.040 |
Why?
| | Ethylmaleimide | 1 | 1997 | 18 | 0.040 |
Why?
| | Inhibitory Postsynaptic Potentials | 1 | 2017 | 32 | 0.040 |
Why?
| | Thionucleotides | 1 | 1997 | 34 | 0.040 |
Why?
| | Biodiversity | 1 | 2021 | 377 | 0.040 |
Why?
| | Dogs | 1 | 2018 | 368 | 0.030 |
Why?
| | Healthy Volunteers | 1 | 2018 | 199 | 0.030 |
Why?
| | Picrotoxin | 1 | 2017 | 13 | 0.030 |
Why?
| | Body Size | 1 | 2018 | 102 | 0.030 |
Why?
| | Nerve Net | 1 | 2020 | 256 | 0.030 |
Why?
| | Oxytocin | 1 | 1997 | 48 | 0.030 |
Why?
| | Quinolines | 2 | 2010 | 155 | 0.030 |
Why?
| | Arizona | 1 | 2016 | 78 | 0.030 |
Why?
| | Patient Reported Outcome Measures | 1 | 2020 | 370 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2024 | 10162 | 0.030 |
Why?
| | Anisotropy | 1 | 2016 | 71 | 0.030 |
Why?
| | 5,7-Dihydroxytryptamine | 1 | 2015 | 3 | 0.030 |
Why?
| | Computational Biology | 1 | 2020 | 597 | 0.030 |
Why?
| | Adrenergic Uptake Inhibitors | 1 | 2015 | 14 | 0.030 |
Why?
| | Organ Size | 1 | 2016 | 441 | 0.030 |
Why?
| | Attention | 1 | 2019 | 433 | 0.030 |
Why?
| | Diffusion Tensor Imaging | 1 | 2016 | 73 | 0.030 |
Why?
| | Thymus Gland | 1 | 2016 | 309 | 0.030 |
Why?
| | Genomics | 1 | 2020 | 715 | 0.030 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2014 | 8 | 0.030 |
Why?
| | Rabbits | 1 | 2016 | 775 | 0.030 |
Why?
| | Environment | 1 | 2017 | 345 | 0.030 |
Why?
| | Freezing Reaction, Cataleptic | 1 | 2014 | 27 | 0.030 |
Why?
| | Mifepristone | 1 | 2014 | 62 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 2018 | 813 | 0.030 |
Why?
| | Executive Function | 1 | 2019 | 424 | 0.030 |
Why?
| | Mice, Inbred ICR | 1 | 2014 | 108 | 0.030 |
Why?
| | Calcium | 1 | 2000 | 1183 | 0.030 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2018 | 320 | 0.030 |
Why?
| | Glutamic Acid | 1 | 2016 | 228 | 0.030 |
Why?
| | Electrochemical Techniques | 1 | 2014 | 48 | 0.030 |
Why?
| | Self-Injurious Behavior | 1 | 2015 | 120 | 0.030 |
Why?
| | Immune System Diseases | 1 | 2014 | 35 | 0.030 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2016 | 510 | 0.030 |
Why?
| | Catalysis | 1 | 2014 | 306 | 0.030 |
Why?
| | Memory Disorders | 1 | 2014 | 163 | 0.030 |
Why?
| | Receptors, Opioid, kappa | 2 | 1990 | 10 | 0.030 |
Why?
| | Heterozygote | 1 | 2014 | 269 | 0.030 |
Why?
| | Mothers | 1 | 1999 | 729 | 0.030 |
Why?
| | Angiotensin II Type 2 Receptor Blockers | 1 | 2013 | 7 | 0.030 |
Why?
| | Adaptation, Physiological | 2 | 2009 | 513 | 0.030 |
Why?
| | Pandemics | 1 | 2021 | 1477 | 0.030 |
Why?
| | Cues | 1 | 2015 | 325 | 0.030 |
Why?
| | Angiotensin II Type 1 Receptor Blockers | 1 | 2013 | 34 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2019 | 1332 | 0.030 |
Why?
| | Odds Ratio | 1 | 2015 | 1019 | 0.030 |
Why?
| | Orexins | 1 | 2012 | 5 | 0.020 |
Why?
| | Androgens | 1 | 1994 | 174 | 0.020 |
Why?
| | Naphthyridines | 1 | 2012 | 16 | 0.020 |
Why?
| | Benzoxazoles | 1 | 2012 | 20 | 0.020 |
Why?
| | Naloxone | 2 | 1990 | 111 | 0.020 |
Why?
| | Sex Factors | 1 | 2018 | 1951 | 0.020 |
Why?
| | Imidazoles | 1 | 2013 | 229 | 0.020 |
Why?
| | Urea | 1 | 2012 | 75 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2019 | 2710 | 0.020 |
Why?
| | Eye Proteins | 2 | 2002 | 88 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2012 | 324 | 0.020 |
Why?
| | Respiration | 1 | 2012 | 190 | 0.020 |
Why?
| | Fetal Development | 1 | 2014 | 284 | 0.020 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2010 | 60 | 0.020 |
Why?
| | Muscle Strength | 1 | 2014 | 304 | 0.020 |
Why?
| | Morphinans | 1 | 1989 | 8 | 0.020 |
Why?
| | Receptors, Opioid, mu | 1 | 1990 | 56 | 0.020 |
Why?
| | Organic Chemicals | 1 | 2010 | 128 | 0.020 |
Why?
| | Morphine | 1 | 1990 | 127 | 0.020 |
Why?
| | Mass Screening | 1 | 2016 | 1146 | 0.020 |
Why?
| | Allylglycine | 1 | 2007 | 2 | 0.020 |
Why?
| | Choline O-Acetyltransferase | 1 | 2007 | 24 | 0.020 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2007 | 26 | 0.020 |
Why?
| | Electric Stimulation | 1 | 2008 | 268 | 0.020 |
Why?
| | Child | 2 | 2019 | 20805 | 0.020 |
Why?
| | Glutamate Decarboxylase | 1 | 2007 | 166 | 0.020 |
Why?
| | Pyrroles | 1 | 2008 | 190 | 0.020 |
Why?
| | Pain | 1 | 2013 | 751 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2014 | 4017 | 0.020 |
Why?
| | Autonomic Nervous System | 1 | 2007 | 75 | 0.020 |
Why?
| | 1-Methyl-4-phenylpyridinium | 1 | 2006 | 5 | 0.020 |
Why?
| | Neural Inhibition | 1 | 2007 | 152 | 0.020 |
Why?
| | Cimetidine | 1 | 1986 | 13 | 0.020 |
Why?
| | Ranitidine | 1 | 1986 | 14 | 0.020 |
Why?
| | Growth Hormone | 1 | 1986 | 96 | 0.020 |
Why?
| | Testis | 1 | 1986 | 144 | 0.020 |
Why?
| | Adolescent | 1 | 2024 | 20304 | 0.010 |
Why?
| | Pyrimidines | 1 | 2008 | 449 | 0.010 |
Why?
| | Statistics, Nonparametric | 1 | 2005 | 419 | 0.010 |
Why?
| | Inspiratory Capacity | 1 | 2004 | 2 | 0.010 |
Why?
| | Single-Blind Method | 1 | 2004 | 268 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2012 | 2269 | 0.010 |
Why?
| | Mutation | 1 | 2014 | 3696 | 0.010 |
Why?
| | Reference Values | 1 | 2004 | 780 | 0.010 |
Why?
| | 5' Flanking Region | 1 | 2001 | 8 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2002 | 369 | 0.010 |
Why?
| | Insect Proteins | 1 | 2001 | 35 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2001 | 267 | 0.010 |
Why?
| | 3' Untranslated Regions | 1 | 2001 | 139 | 0.010 |
Why?
| | Microsatellite Repeats | 1 | 2001 | 161 | 0.010 |
Why?
| | Periodicity | 1 | 2000 | 56 | 0.010 |
Why?
| | Introns | 1 | 2001 | 250 | 0.010 |
Why?
| | DNA Primers | 1 | 2001 | 510 | 0.010 |
Why?
| | Drosophila | 1 | 2001 | 142 | 0.010 |
Why?
| | Exons | 1 | 2001 | 339 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2017 | 14471 | 0.010 |
Why?
| | Pyramidal Cells | 1 | 1999 | 70 | 0.010 |
Why?
| | Atrophy | 1 | 1999 | 170 | 0.010 |
Why?
| | Molecular Sequence Data | 1 | 2002 | 2822 | 0.010 |
Why?
| | RNA, Complementary | 1 | 1997 | 3 | 0.010 |
Why?
| | Sulfur Radioisotopes | 1 | 1997 | 16 | 0.010 |
Why?
| | Thyrotropin-Releasing Hormone | 1 | 1997 | 12 | 0.010 |
Why?
| | Oligonucleotide Probes | 1 | 1997 | 50 | 0.010 |
Why?
| | Neuronal Plasticity | 1 | 1999 | 265 | 0.010 |
Why?
| | Body Mass Index | 1 | 2000 | 2263 | 0.010 |
Why?
| | Testosterone | 1 | 1994 | 370 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2000 | 5371 | 0.000 |
Why?
| | Dyspepsia | 1 | 1986 | 10 | 0.000 |
Why?
| | Gonadal Steroid Hormones | 1 | 1986 | 129 | 0.000 |
Why?
| | Glucose Tolerance Test | 1 | 1986 | 356 | 0.000 |
Why?
| | Insulin | 1 | 1986 | 2316 | 0.000 |
Why?
|
|
Lowry's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|